1. AML refractory to primary induction with Ida-FLAG has a poor clinical outcome. (May 2018) Authors: Kavanagh, Simon; Heath, Emily; Hurren, Rose; Gronda, Marcela; Barghout, Samir H.; Liyanage, Sanduni U.; Siriwardena, Thirushi P.; Claudio, Jaime; Zhang, Tong; Sukhai, Mahadeo; Stockley, Tracy L.; Kamel-Reid, Suzanne; Rostom, Amr; Lutynski, Andrzej; Khalaf, Dina; Rydlewski, Anna; Chan, Steven M.; ... Journal: Leukemia research Issue: Volume 68(2018) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms. Issue 11 (8th April 2016) Authors: Malherbe, Jacques A J; Fuller, Kathryn A; Mirzai, Bob; Kavanagh, Simon; So, Chi-Chiu; Ip, Ho-Wan; Guo, Belinda B; Forsyth, Cecily; Howman, Rebecca; Erber, Wendy N Journal: Journal of clinical pathology Issue: Volume 69:Issue 11(2016) Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Emerging alternatives to tyrosine kinase inhibitors for treating chronic myeloid leukemia. (2nd January 2018) Authors: Kavanagh, Simon; Nee, Aisling; Lipton, Jeffrey H. Journal: Expert opinion on emerging drugs Issue: Volume 23:Number 1(2018) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TGFα expression in myeloid malignancies. Issue 6 (16th March 2016) Authors: Kavanagh, Simon; Mirzai, Bob; Fuller, Kathy; Erber, Wendy N Journal: Journal of clinical pathology Issue: Volume 69:Issue 6(2016) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗